Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

429.85
+5.931.40%
Post-market: 425.10-4.7468-1.10%19:59 EDT
Volume:1.42M
Turnover:606.39M
Market Cap:109.06B
PE:28.06
High:430.13
Open:423.75
Low:422.11
Close:423.92
52wk High:509.00
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.49
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:5.84
PE(LYR):28.06

Loading ...

Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines

TIPRANKS
·
2 hours ago

Vertex Pharmaceuticals Ends Study of Cystic Fibrosis Drug Over Tolerability Issues

Dow Jones
·
3 hours ago

Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals

TIPRANKS
·
3 hours ago

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
5 hours ago

Vertex Q1 adjusted EPS beats estimates, revenue rises 8%

Reuters
·
6 hours ago

GUIDANCE: (VRTX) Vertex Pharmaceuticals Expects 2026 Revenue Range $12.95B-$13.1B, vs. FactSet Est of $13.05B

MT Newswires Live
·
6 hours ago

Vertex Pharmaceuticals Q1 Adj. EPS $4.47 Beats $4.31 Estimate, Sales $2.987B Miss $3.032B Estimate

Benzinga
·
6 hours ago

Vertex Q1 FY26 GAAP net income rises to $1 billion; revenue increases 8% to $2.99 billion

Reuters
·
6 hours ago

Vertex tops profit estimates as sales of new cystic fibrosis drug surge

Reuters
·
6 hours ago

BRIEF-Vertex Pharmaceuticals Q1 Adjusted EPS USD 4.47 Vs. IBES Estimate USD 4.31

Reuters
·
6 hours ago

Vertex Pharmaceuticals Inc: Reiterates Full Year 2026 Financial Guidance

THOMSON REUTERS
·
6 hours ago

Vertex Pharmaceuticals Inc Q1 Adj EPS $4.47 VS Ibes Estimate of $4.31

THOMSON REUTERS
·
6 hours ago

U.S. Earnings Preview: After Market Close May 4

Dow Jones
·
6 hours ago

Vertex options imply 5.5% move in share price post-earnings

TIPRANKS
·
7 hours ago

Tyson Foods, Williams Companies And 3 Stocks To Watch Heading Into Monday

Benzinga
·
Yesterday

Vertex Pharmaceuticals Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
May 01

Vertex price target lowered to $18 from $20 at Morgan Stanley

TIPRANKS
·
May 01

How Cautious Earnings Sentiment Ahead of Q1 Results Will Impact Vertex Pharmaceuticals (VRTX) Investors

Simply Wall St.
·
Apr 30

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 30

Vertex director Suketu Upadhyay to step down, won’t seek re-election at annual meeting

Reuters
·
Apr 30